Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nitric oxide in migraine.

L Neeb1, U Reuter

  • 1Charité Campus Mitte, Universitätsmedizin Berlin, Department of Neurology, Charitéplatz 1, 10117, Berlin, Germany.

CNS & Neurological Disorders Drug Targets
|August 19, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Digitalization in headache therapy].

Schmerz (Berlin, Germany)·2020
Same author

[Treatment of chronic migraine with botulinum neurotoxin A : Expert recommendations of the German Migraine and Headache Society].

Der Nervenarzt·2018
Same author

Headache and pregnancy: a systematic review.

The journal of headache and pain·2017
Same author

Prevalence of low back pain in adolescent athletes - an epidemiological investigation.

International journal of sports medicine·2014
Same author

Peripheral endothelial function and arterial stiffness in women with migraine with aura: a case-control study.

Cephalalgia : an international journal of headache·2012
Same author

Migraines with and without aura and their response to preventive therapy with topiramate.

Cephalalgia : an international journal of headache·2009
Same journal

Role of Cholesterol Metabolism in the Link Between Diabetes and Alzheimer's Disease.

CNS & neurological disorders drug targets·2026
Same journal

Linking Neurodegeneration and Age-related Macular Degeneration: Unified Pathways and Intervention Strategies.

CNS & neurological disorders drug targets·2026
Same journal

Modulating the Microbiota-gut-brain Axis: A Promising Strategy for Alzheimer's Disease Prevention and Management.

CNS & neurological disorders drug targets·2026
Same journal

The Therapeutic Effects of Dietary Supplements on OCD: A Narrative Review.

CNS & neurological disorders drug targets·2026
Same journal

Amyotrophic Lateral Sclerosis: Therapeutic Innovations and Evolving Regulatory Approaches.

CNS & neurological disorders drug targets·2026
Same journal

Pathogenic Proteins Driving ALS Pathogenesis: Molecular Mechanisms and Translational Therapeutic Perspectives.

CNS & neurological disorders drug targets·2026
See all related articles

Nitric oxide (NO), a key molecule in migraine, induces attacks via pathways involving nuclear factor-kappaB (NF-kappaB). Understanding NO"s role may reveal new migraine treatment targets.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Biochemistry

Background:

  • Nitric oxide (NO) is a potent vasodilator and messenger molecule implicated in migraine pathogenesis.
  • Glyceryl trinitrate (GTN), an NO donor, can trigger migraine attacks in susceptible individuals with a 4-6 hour latency.

Purpose of the Study:

  • To review the roles of nitric oxide (NO) and nuclear factor-kappaB (NF-kappaB) in human and animal models of migraine pathophysiology.
  • To explore the mechanisms underlying the GTN-induced migraine response and its relation to NO pathways.
  • To assess the involvement of NO pathways in the efficacy of preventative migraine medications.

Main Methods:

  • Review of existing literature on nitric oxide, NF-kappaB, and migraine.
  • Analysis of human and animal studies investigating NO-mediated pain, inflammation, and central sensitization.

Related Experiment Videos

  • Examination of the cyclic guanosine monophosphate (cGMP)-dependent mechanisms of NO action.

    • Main Results:

    • NO is involved in pain transmission, hyperalgesia, chronic pain, inflammation, and central sensitization, often via cGMP-dependent pathways.
    • Experimental models provide insights into the human GTN response, highlighting NO's role in migraine induction.
    • Preventative migraine drugs may exert their effects through modulation of NO pathways.

    Conclusions:

    • Nitric oxide plays a significant role in the induction of migraine attacks.
    • Understanding NO's involvement offers potential therapeutic targets for both acute and preventative migraine treatments.
    • Further research into NO pathways is crucial for developing novel migraine therapies.